Inhibition of lysine acetyltransferases impairs tumor angiogenesis acting on both endothelial and tumor cells

BACKGROUND: Understanding the signalling pathways involved in angiogenesis, and developing anti-angiogenic drugs are one of the major focuses on cancer research. Herein, we assessed the effect of CPTH6, a lysine acetyltransferase inhibitor and anti-tumoral compound, on angiogenesis-related propertie...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Exp Clin Cancer Res
Autors principals: Di Martile, Marta, Gabellini, Chiara, Desideri, Marianna, Matraxia, Marta, Farini, Valentina, Valentini, Elisabetta, Carradori, Simone, Ercolani, Cristiana, Buglioni, Simonetta, Secci, Daniela, Andreazzoli, Massimiliano, Del Bufalo, Donatella, Trisciuoglio, Daniela
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7273677/
https://ncbi.nlm.nih.gov/pubmed/32498717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-020-01604-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars